A recent meta-analysis confirms that circulating chemerin is elevated in MAFLD and NAFLD but not consistently in NASH, indicating that chemerin reflects metabolic dysfunction and steatosis more reliably than histological severity [65]. This evidence concerns the gene RARRES2 and metabolic dysfunction-associated steatohepatitis.